1 Quaker Chemical Corporation Investor Conference Call April 30, 2014 First Quarter 2014 Results

Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company and allows investors to better evaluate the financial results of the Company. These measures should not be viewed as an alternative to GAAP measures of performance. Furthermore, these measures may not be consistent with similar measures provided by other companies. This data should be read in conjunction with the Company’s first quarter earnings news release dated April 29, 2014, which has been furnished to the SEC on Form 8-K, and the Company’s Form 10-Q for the quarterly period ended March 31, 2014, which has been filed with the SEC. Forward-Looking Statements This presentation may contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Company’s demand is largely derived from the demand for its customers’ products, which subjects the Company to downturns in a customer’s business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995. Risks and Uncertainties Statement

Speakers Chart #1 Michael F. Barry Chairman of the Board, Chief Executive Officer & President Margaret M. Loebl Vice President, Chief Financial Officer & Treasurer Robert T. Traub General Counsel

First Quarter 2014 Headlines ▪ 3% revenue growth despite impacts from foreign exchange and the U.S. winter ▪ 11% growth in operating income and adjusted EBITDA ▪ Stable margin levels contribute to improved operating results Chart #2

Chairman Comments First Quarter 2014 ▪ First Quarter 2014 x Solid volume levels across most regions x Stable margins despite select market challenges x Strong operating results x Effective business model and competitive position x Liquidity remains a Company strength ▪ 2014 Outlook x Modest growth with challenges in Brazil & India x Furthering share gains and leverage from acquisitions x Some increases in raw material costs x Continue to actively pursue acquisitions “Overall, I continue to remain confident in our future and expect 2014 to be another good year for Quaker as we strive to increase revenue and earnings for the fifth consecutive year.” -- Michael F. Barry, Chairman, CEO & President Chart #3

Product Volume by Quarter Thousand Kilograms 25,000 30,000 35,000 40,000 45,000 50,000 55,000 4Q08 YTD Avg. 1Q092Q093Q094Q091Q102Q103Q104Q101Q112Q113Q114Q111Q122Q123Q124Q121Q132Q133Q134Q131Q14 Chart #4

Financial Snapshot Q1 2014 Q1 2013 Net Sales ($Mils.) 181.7 176.2 Gross Margin (%) 35.8 35.5 Operating Margin (%) 10.7 9.9 Net Income attributable to Quaker Chemical Corporation ($Mils.) 12.7 13.6 Adjusted EBITDA ($Mils.) – Trailing Twelve Months 92.0 81.9 Adjusted EBITDA Margin (%) 12.5 11.6 Earnings Per Diluted Share 0.96 1.04 Non - GAAP Earnings Per Diluted Share 0.95 0.96 Debt ($Mils.) 18.5 29.6 Equity ($Mils.) 358.0 302.0 Net Operating Cash Flow ($Mils.) (1.8) 11.3 Chart #5

Gross Margin Percentage 28.0% 34.7% 35.4% 32.6% 33.7% 35.8% 20.0% 25.0% 30.0% 35.0% 40.0% 2008 2009 2010 2011 2012 2013 Gross Margin Percentage 35.5% 36.4% 35.9% 35.4% 35.8% 20.0% 25.0% 30.0% 35.0% 40.0% Q1 2013 Q2 2013 Q3 2013 Q4 2013 Q1 2014 Gross Margin Percentage Chart #6

Adjusted EBITDA Baseline Historical Performance $40.1 $44.2 $66.8 $73.0 $80.9 $89.6 $95.0 6.90% 9.80% 12.30% 10.70% 11.40% 12.30% 13.10% 2008 2009 2010 2011 2012 2013 Q1 2014 Annualized Adjusted EBITDA ($ Mils.) Adjusted EBITDA Margin (%) 2008 – 2014 Annualized CAGR: 15.5% +620 Margin bps Chart #7

Balance Sheet Net Cash / (Debt) -$100 -$80 -$60 -$40 -$20 $0 $20 $40 $60 $80 2008 2009 2010 2011 2012 2013 Q1 2014 $ Millions Cash ST/LT Debt Net Debt Chart #8

APPENDIX

Non - GAAP Earnings Per Diluted Share Reconciliation Q1 2014 Q1 2013 GAAP Earnings Per Diluted Share 0.96$ 1.04$ UK pension plan amendment per diluted share 0.05$ -$ Devaluation of the Venezuelan Bolivar Fuerte per diluted share -$ 0.03$ Equity income in a captive insurance company per diluted share (0.06)$ (0.11)$ Non-GAAP Earnings Per Diluted Share 0.95$ 0.96$ Chart #9

Annualized Adjusted EBITDA Reconciliation 2008 2009 2010 2011 2012 2013 YTD Q1 2014 Net income 9,833 16,058 32,120 45,892 47,405 56,339 12,730 Depreciation 10,879 9,525 9,867 11,455 12,252 12,339 3,075 Amortization 1,177 1,078 988 2,338 3,106 3,445 813 Interest expense 5,509 5,533 5,225 4,666 4,283 2,922 525 Taxes on income 4,977 7,065 12,616 14,256 15,575 20,489 6,546 Restructuring and related activities 2,916 2,289 - - - - - Non-income tax contingency charge - - 4,132 - - 796 - Equity affiliate out of period charge - - 564 - - - - Mineral oil excise tax refund - - - - - (2,540) - Transition costs related to key employees 3,505 2,443 1,317 - 609 - - Non-cash gain from the purchase of an equity affiliate - - - (2,718) - - - Change in acquisition-related earnout liability - - - (595) (1,737) (497) - Equity loss (income) from a captive insurance company 1,299 162 (313) (2,323) (1,812) (5,451) (846) Devaluation of the Venezuelan Bolivar - - 322 - - 357 - U.S customer bankruptcies - - - - 1,254 - - Cost streamlining initiatives - - - - - 1,419 - UK pension plan amendment - - - - - - 902 Adjusted EBITDA 40,095 44,153 66,838 72,971 80,935 89,618 23,745 Adjusted EBITDA Margin 6.9% 9.8% 12.3% 10.7% 11.4% 12.3% 13.1% Multiply Adjusted EBITDA by Annual Run Rate 1 1 1 1 1 1 4 Annualized Adjusted EBITDA 40,095 44,153 66,838 72,971 80,935 89,618 94,980 Chart #10

Trailing Twelve Months Adjusted EBITDA Reconciliation I = G + H H G = F - D F E = C + D D C = B - A B A Trailing Twelve Months Q1 2014 Q1 2014 Last Nine Months 2013 YTD 2013 Trailing Twelve Months Q1 2013 Q1 2013 Last Nine Months 2012 YTD 2012 Q1 2012 Net income 55,450 12,730 42,720 56,339 48,659 13,619 35,040 47,405 12,365 Depreciation 12,358 3,075 9,283 12,339 12,251 3,056 9,195 12,252 3,057 Amortization 3,379 813 2,566 3,445 3,239 879 2,360 3,106 746 Interest expense 2,703 525 2,178 2,922 3,853 744 3,109 4,283 1,174 Taxes on income 22,902 6,546 16,356 20,489 16,263 4,133 12,130 15,575 3,445 Non-income tax contingency 796 - 796 796 - - - - - Mineral oil excise tax refund (2,540) - (2,540) (2,540) - - - - Non-cash gain from the purchase of an equity affiliate - - - - - - - - - Change in acquisition-related earnout liability (497) - (497) (497) (1,737) - (1,737) (1,737) - Equity loss (income) from a captive insurance company (4,862) (846) (4,016) (5,451) (2,828) (1,435) (1,393) (1,812) (419) Devaluation of the Venezuelan Bolivar - - - 357 357 357 - - - U.S. customer bankruptcies - - - - 1,254 - 1,254 1,254 - Transition costs related to key employees - - - - 609 - 609 609 - Cost streamlining initiatives 1,419 1,419 1,419 - - - - - UK pension plan amendment 902 902 - - - - - - - Adjusted EBITDA 92,010 23,745 68,265 89,618 81,920 21,353 60,567 80,935 20,368 Adjusted EBITDA Margin 12.5% 13.1% 12.3% 12.3% 11.6% 12.1% 11.4% 11.4% 11.5% Chart #11